HBM-7015

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHBM-7015
Drug Alias NameHBM7015HBM-7015R-7015
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTransforming growth factor beta 1 inhibitorsProgrammed death-ligand 1 blockers
TargetsTransforming growth factor beta 1Programmed death-ligand 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarbour Biomed
China Registration ClassN/A

Develop Information

Active CompaniesHarbour BiomedHualan Ankang Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A